Cover Story
The Centers for Medicare and Medicaid Services appear to be executing a two-step strategy to shrink the $8 billion annual price tag of clinical diagnostic laboratory tests.
In Brief
Funding Opportunities
Drugs & Targets
Trending Stories
- In 1971, Chris Lundy had minute odds of survival. He is now the longest living BMT recipient at the Hutch
- How Beth Carner went from six weeks left to live with stage 4 colon cancer to complete remission
- Canine cancers as models: We have barely tapped the full potential of comparative oncology
- Over three years as CEO, Karen Knudsen led ACS through COVID—and reversed the charity’s long slump
- Cold Spring Harbor and Northwell extend collaboration with $150M commitment
- FDA approves Anktiva for non-muscle-invasive bladder cancer